Genome News and Research

RSS

Supercomputer simulations illuminate the behavior of dominant G form of SARS-CoV-2

Large-scale supercomputer simulations at the atomic level show that the dominant G form variant of the COVID-19-causing virus is more infectious partly because of its greater ability to readily bind to its target host receptor in the body, compared to other variants.

17 Apr 2021

Novel CRISPR-based technology may lead to powerful epigenetic therapies

Scientists have figured out how to modify CRISPR's basic architecture to extend its reach beyond the genome and into what's known as the epigenome -- proteins and small molecules that latch onto DNA and control when and where genes are switched on or off.

17 Apr 2021

Candidate coronavirus vaccines show promising results in early animal testing

A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.

17 Apr 2021

Study reveals new lineage of tuberculosis-causing bacteria in the eastern part of the continent

Mireia Coscollá, a researcher at the Institute for Integrative Systems Biology (I2SysBio), a joint centre of the University of Valencia and the Spanish National Research Council, has led a study on the bacterium that causes tuberculosis, one of the 10 deadliest diseases in the world, which proves the existence of a new lineage.

16 Apr 2021

Genetic variants that impact protein binding in immune cells can cause autoimmune diseases

Certain genetic variants that cause modified protein binding in immune cells, are also seen in those at high risk of some autoimmune diseases, new research has found.

16 Apr 2021

HP1a is a key epigenetic regulator that maintains chromosome integrity

The information of the human genome is encoded by approximately 3 billion DNA base pairs and packaged into 23 pairs of chromosomes.

16 Apr 2021

“Expansion Hunter” method can detect DNA errors that lead to repeat expansion diseases

Detecting hidden genetic defects by applying an existing method to an existing datasets. Researchers at Radboud university medical center have succeeded.

16 Apr 2021

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

A number of SARS-CoV-2 variants have emerged from immunocompromised hosts, research has identified. It is thought that variants of concern - including B.1.1.7, a variant first identified in Kent - were a result of long-term infection in people with a weakened immune system.

16 Apr 2021

Japanese–European scientists detect novel genetic mitochondrial disorder

The list of known genetic mitochondrial disorders is ever-growing, and ongoing research continues to identify new disorders in this category.

15 Apr 2021

New genetic markers may lead to personalized treatments for lung cancer

Investigators at Wake Forest School of Medicine, part of Wake Forest Baptist Health, have identified a set of new genetic markers that could potentially lead to new personalized treatments for lung cancer.

15 Apr 2021

Study solves mystery of how cells measure their size

Scientists have searched for years to understand how cells measure their size. Cell size is critical. It's what regulates cell division in a growing organism.

15 Apr 2021

Ebola virus's key protein uses molecular triggers in the human cell to change shape

The human genome contains the instructions to make tens of thousands of proteins. Each protein folds into a precise shape - and biologists are taught that defined shape dictates the protein's destined function.

15 Apr 2021

SARS-CoV-2 variants are widely spread across the Houston metropolitan area

In late 2020, several concerning SARS-CoV-2 variants emerged globally. They are believed to be more easily transmissible, and there is concern that some may reduce the effectiveness of antibody treatments and vaccines.

14 Apr 2021

SARS-CoV-2 mutations impact T-cell recognition of virus

A new research paper posted to the bioRxiv preprint server deals with the impact of these mutations on adaptive cellular immunity.

14 Apr 2021

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

The study, published in The Lancet, demonstrates that there is no evidence of a link between severe illness and death and lineage when comparing the B.1.1.7 lineage and other variants.

14 Apr 2021

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared with those infected with a different COVID-19 strain.

13 Apr 2021

Researchers develop model for SARS-CoV-2 fusion intermediate that helps membrane fusion

The spike protein is the main part of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the infection. It consists of two subunits S1 and S2. Upon entry of the virus into the human body, the S1 subunit helps the virus bind to the angiotensin-converting enzyme 2 (ACE2) receptors on host cells.

13 Apr 2021

A host of mutations could compromise COVID-19 vaccines and antibody therapies

Researchers in the United States have identified 95 high-frequency mutations in the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that threaten to compromise the efficacy of current and future vaccines and antibody therapies for coronavirus disease 2019 (COVID-19).

13 Apr 2021

DNA supercoiling is involved in the control of gene expression

The (when stretched) two-meter-long DNA molecule in each human cell is continuously being unpacked and packed again to enable the expression of genetic information.

13 Apr 2021

New approach to scale up genome editing in tiny worms

Understanding the effects of specific mutations in gene regulatory regions - the sections of DNA and RNA that turn genes on and off - is important to unraveling how the genome works, as well as normal development and disease.

13 Apr 2021

Genome News and Research

Supercomputer simulations illuminate the behavior of dominant G form of SARS-CoV-2

Novel CRISPR-based technology may lead to powerful epigenetic therapies

Candidate coronavirus vaccines show promising results in early animal testing

Study reveals new lineage of tuberculosis-causing bacteria in the eastern part of the continent

Genetic variants that impact protein binding in immune cells can cause autoimmune diseases

HP1a is a key epigenetic regulator that maintains chromosome integrity

“Expansion Hunter” method can detect DNA errors that lead to repeat expansion diseases

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

Japanese–European scientists detect novel genetic mitochondrial disorder

New genetic markers may lead to personalized treatments for lung cancer

Study solves mystery of how cells measure their size

Ebola virus's key protein uses molecular triggers in the human cell to change shape

SARS-CoV-2 variants are widely spread across the Houston metropolitan area

SARS-CoV-2 mutations impact T-cell recognition of virus

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Researchers develop model for SARS-CoV-2 fusion intermediate that helps membrane fusion

A host of mutations could compromise COVID-19 vaccines and antibody therapies

DNA supercoiling is involved in the control of gene expression

New approach to scale up genome editing in tiny worms

The art of CRISPR: The power and promise of gene editing eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News